CEBAM | ACP | HAS | KDIGO | KHA-CARI | BCMA | UMHS | VA-DoD | NICE | ||
---|---|---|---|---|---|---|---|---|---|---|
2012 | 2013 | 2013 | 2013 | 2013 | 2014 | 2014 | 2014 | 2015 | ||
Referral Criteria | ||||||||||
general | consider individual preferences | ▪ | ▪ | |||||||
consider individual comorbidities | ▪ | ▪ | ||||||||
cooperation or multidisciplinary care | ▪ | i | ▪ | ▪ | ▪ | |||||
routine follow-up after referral by patient’s GP | ▪ | ▪ | ||||||||
nephrologist | GFR < 60 ml/min/1,73m2 | |||||||||
GFR < 45 ml/min/1,73m2 | i | ▪ | ||||||||
GFR < 30 ml/min/1,73m2 | ▪ | ▪ | ▪ | ▪ | ▪ | ▪ | ▪ | |||
ACR > 30 mg/mmol | ▪* | ▪ | ▪ | + hematuria | ||||||
ACR ≥70 mg/mmol | ▪ | i# | ||||||||
proteinuria > 3500 mg/day | ▪ | |||||||||
hematuria | i | ▪* | ||||||||
urinary cell casts | ▪ | |||||||||
constitutional symptoms | ▪ | |||||||||
CKD progression | ▪ | ▪ | ▪ | ▪ | ▪ | ▪ | ▪ | |||
poorly controlled hypertension | ▪ | ▪ | ▪ | ▪ | ||||||
electrolyte disturbance | i | ▪ | ▪ | ▪ | ||||||
anemia | i | ▪ | ▪ | |||||||
metabolic complications | i | ▪ | ||||||||
complications | i | i | ||||||||
nephrolythiasis | ▪ | ▪ | ||||||||
suspected renal artery stenosis | ▪ | ▪ | ||||||||
genetic etiology of CKD | ▪ | ▪ | ▪ | |||||||
rare etiology of CKD | ▪ | |||||||||
etiology requiring specialist care | ▪ | |||||||||
unclear etiology | i | i | ▪ | |||||||
1-year ESRD-risk of ≥10% | ▪ | |||||||||
indication for dialysis or transplant | ▪ | ▪ | ▪ | |||||||
urologist | renal outflow obstruction | ▪ | ▪ | |||||||
diabetologist | diabetic nephropathy | ▪ | ▪ | |||||||
dietician | eGFR< 60 ml/min/1,73m2 | ▪ | i | i | ||||||
inpatient treatment | complications | ▪ | ||||||||
hypertensive crisis | ▪ | |||||||||
unknown etiology | ▪ |